Reply
[...]in PRO-TEE, the use of thrombolysis irrespective of thrombus size in some centers provided a wide range of thrombus burden and allowed the evaluation of the relation of thrombus size to complications. The complication rate observed in PRO-TEE (embolic rate: 14%; death rate: 5.6%) was similar to...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2005-01, Vol.45 (2), p.326 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 326 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 45 |
| creator | Tong, Ann T Roudaut, Raymond Özkan, Mehmet Sagie, Alex Shahid, Maie SA Pontes, Sergio C Carreras, Francesc Girard, Steven E Arnaout, Samir Stainback, Raymond F Thadani, Ravi Zoghbi, William A |
| description | [...]in PRO-TEE, the use of thrombolysis irrespective of thrombus size in some centers provided a wide range of thrombus burden and allowed the evaluation of the relation of thrombus size to complications. The complication rate observed in PRO-TEE (embolic rate: 14%; death rate: 5.6%) was similar to reported series not using TEE to guide therapy, pointing to less selection bias. [...]we maintain that TEE is essential in the management of patients with suspected PVT. The PRO-TEE registry, although retrospective, identified for the first time the threshold of a "small clot" beyond which risk of complications increases with thrombolysis. |
| doi_str_mv | 10.1016/j.jacc.2004.10.029 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1506159688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3242613251</sourcerecordid><originalsourceid>FETCH-proquest_journals_15061596883</originalsourceid><addsrcrecordid>eNpjYJAyNNAzNDA008_Sy0pMTtYzMjAwAQroGRhZMjFwGpqaWugam1qaszBwGpgbm-oaGliaczBwFRdnGRgYmFkYWnIysAalFuRU8jCwpiXmFKfyQmluBmU31xBnD92CovzC0tTikvis_NKiPKBUvKGpgZmhqaWZhYUxcaoAQQcqYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506159688</pqid></control><display><type>article</type><title>Reply</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Tong, Ann T ; Roudaut, Raymond ; Özkan, Mehmet ; Sagie, Alex ; Shahid, Maie SA ; Pontes, Sergio C ; Carreras, Francesc ; Girard, Steven E ; Arnaout, Samir ; Stainback, Raymond F ; Thadani, Ravi ; Zoghbi, William A</creator><creatorcontrib>Tong, Ann T ; Roudaut, Raymond ; Özkan, Mehmet ; Sagie, Alex ; Shahid, Maie SA ; Pontes, Sergio C ; Carreras, Francesc ; Girard, Steven E ; Arnaout, Samir ; Stainback, Raymond F ; Thadani, Ravi ; Zoghbi, William A</creatorcontrib><description>[...]in PRO-TEE, the use of thrombolysis irrespective of thrombus size in some centers provided a wide range of thrombus burden and allowed the evaluation of the relation of thrombus size to complications. The complication rate observed in PRO-TEE (embolic rate: 14%; death rate: 5.6%) was similar to reported series not using TEE to guide therapy, pointing to less selection bias. [...]we maintain that TEE is essential in the management of patients with suspected PVT. The PRO-TEE registry, although retrospective, identified for the first time the threshold of a "small clot" beyond which risk of complications increases with thrombolysis.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2004.10.029</identifier><language>eng</language><publisher>New York: Elsevier Limited</publisher><subject>Blood clots ; Cardiology ; Drug therapy ; Mortality ; Patients ; Prostheses ; Stroke ; Surgery ; Valves</subject><ispartof>Journal of the American College of Cardiology, 2005-01, Vol.45 (2), p.326</ispartof><rights>Copyright Elsevier Limited Jan 18, 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Tong, Ann T</creatorcontrib><creatorcontrib>Roudaut, Raymond</creatorcontrib><creatorcontrib>Özkan, Mehmet</creatorcontrib><creatorcontrib>Sagie, Alex</creatorcontrib><creatorcontrib>Shahid, Maie SA</creatorcontrib><creatorcontrib>Pontes, Sergio C</creatorcontrib><creatorcontrib>Carreras, Francesc</creatorcontrib><creatorcontrib>Girard, Steven E</creatorcontrib><creatorcontrib>Arnaout, Samir</creatorcontrib><creatorcontrib>Stainback, Raymond F</creatorcontrib><creatorcontrib>Thadani, Ravi</creatorcontrib><creatorcontrib>Zoghbi, William A</creatorcontrib><title>Reply</title><title>Journal of the American College of Cardiology</title><description>[...]in PRO-TEE, the use of thrombolysis irrespective of thrombus size in some centers provided a wide range of thrombus burden and allowed the evaluation of the relation of thrombus size to complications. The complication rate observed in PRO-TEE (embolic rate: 14%; death rate: 5.6%) was similar to reported series not using TEE to guide therapy, pointing to less selection bias. [...]we maintain that TEE is essential in the management of patients with suspected PVT. The PRO-TEE registry, although retrospective, identified for the first time the threshold of a "small clot" beyond which risk of complications increases with thrombolysis.</description><subject>Blood clots</subject><subject>Cardiology</subject><subject>Drug therapy</subject><subject>Mortality</subject><subject>Patients</subject><subject>Prostheses</subject><subject>Stroke</subject><subject>Surgery</subject><subject>Valves</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpjYJAyNNAzNDA008_Sy0pMTtYzMjAwAQroGRhZMjFwGpqaWugam1qaszBwGpgbm-oaGliaczBwFRdnGRgYmFkYWnIysAalFuRU8jCwpiXmFKfyQmluBmU31xBnD92CovzC0tTikvis_NKiPKBUvKGpgZmhqaWZhYUxcaoAQQcqYA</recordid><startdate>20050118</startdate><enddate>20050118</enddate><creator>Tong, Ann T</creator><creator>Roudaut, Raymond</creator><creator>Özkan, Mehmet</creator><creator>Sagie, Alex</creator><creator>Shahid, Maie SA</creator><creator>Pontes, Sergio C</creator><creator>Carreras, Francesc</creator><creator>Girard, Steven E</creator><creator>Arnaout, Samir</creator><creator>Stainback, Raymond F</creator><creator>Thadani, Ravi</creator><creator>Zoghbi, William A</creator><general>Elsevier Limited</general><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20050118</creationdate><title>Reply</title><author>Tong, Ann T ; Roudaut, Raymond ; Özkan, Mehmet ; Sagie, Alex ; Shahid, Maie SA ; Pontes, Sergio C ; Carreras, Francesc ; Girard, Steven E ; Arnaout, Samir ; Stainback, Raymond F ; Thadani, Ravi ; Zoghbi, William A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_15061596883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Blood clots</topic><topic>Cardiology</topic><topic>Drug therapy</topic><topic>Mortality</topic><topic>Patients</topic><topic>Prostheses</topic><topic>Stroke</topic><topic>Surgery</topic><topic>Valves</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tong, Ann T</creatorcontrib><creatorcontrib>Roudaut, Raymond</creatorcontrib><creatorcontrib>Özkan, Mehmet</creatorcontrib><creatorcontrib>Sagie, Alex</creatorcontrib><creatorcontrib>Shahid, Maie SA</creatorcontrib><creatorcontrib>Pontes, Sergio C</creatorcontrib><creatorcontrib>Carreras, Francesc</creatorcontrib><creatorcontrib>Girard, Steven E</creatorcontrib><creatorcontrib>Arnaout, Samir</creatorcontrib><creatorcontrib>Stainback, Raymond F</creatorcontrib><creatorcontrib>Thadani, Ravi</creatorcontrib><creatorcontrib>Zoghbi, William A</creatorcontrib><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tong, Ann T</au><au>Roudaut, Raymond</au><au>Özkan, Mehmet</au><au>Sagie, Alex</au><au>Shahid, Maie SA</au><au>Pontes, Sergio C</au><au>Carreras, Francesc</au><au>Girard, Steven E</au><au>Arnaout, Samir</au><au>Stainback, Raymond F</au><au>Thadani, Ravi</au><au>Zoghbi, William A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2005-01-18</date><risdate>2005</risdate><volume>45</volume><issue>2</issue><spage>326</spage><pages>326-</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>[...]in PRO-TEE, the use of thrombolysis irrespective of thrombus size in some centers provided a wide range of thrombus burden and allowed the evaluation of the relation of thrombus size to complications. The complication rate observed in PRO-TEE (embolic rate: 14%; death rate: 5.6%) was similar to reported series not using TEE to guide therapy, pointing to less selection bias. [...]we maintain that TEE is essential in the management of patients with suspected PVT. The PRO-TEE registry, although retrospective, identified for the first time the threshold of a "small clot" beyond which risk of complications increases with thrombolysis.</abstract><cop>New York</cop><pub>Elsevier Limited</pub><doi>10.1016/j.jacc.2004.10.029</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2005-01, Vol.45 (2), p.326 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1506159688 |
| source | Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Blood clots Cardiology Drug therapy Mortality Patients Prostheses Stroke Surgery Valves |
| title | Reply |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T06%3A41%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Tong,%20Ann%20T&rft.date=2005-01-18&rft.volume=45&rft.issue=2&rft.spage=326&rft.pages=326-&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2004.10.029&rft_dat=%3Cproquest%3E3242613251%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1506159688&rft_id=info:pmid/&rfr_iscdi=true |